N-acetylcysteine - Passe-partout or much ado about nothing?

British Journal of Clinical Pharmacology

Volumn 61, Issue 1, 2006, Pages 5-15

  Aitio, Mirja Liisa ^a,b  

^a Clinical Pharmacology and Nephrology ^*

^b Clinical Pharmacology and Nephrology   (Switzerland)

Author keywords

Antioxidant treatment; HIV infection; N acetylcysteine; Pulmonary disease; Radiocontrast induced nephropathy

Indexed keywords

ACETYLCYSTEINE; ALPHA INTERFERON; AMPHOTERICIN; ANTIOXIDANT; BUSULFAN; CADMIUM; CAPTOPRIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYSTATIN C; DIMETHYL SULFOXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GENTAMICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOSORBIDE DINITRATE; MERCURIC CHLORIDE; METHOTREXATE; MUCOLYTIC AGENT; NEVIRAPINE; PARACETAMOL; RETINOL; TUMOR NECROSIS FACTOR ALPHA; VITAMIN B GROUP;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; CANCER RECURRENCE; CARDIOPULMONARY BYPASS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COST CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INTOXICATION; DRUG SCREENING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIVER FAILURE; LIVER INJURY; LUNG DISEASE; META ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; SYSTEMATIC REVIEW; TOXIC EPIDERMAL NECROLYSIS;

ACETYLCYSTEINE; ANTI-HIV AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; EXPECTORANTS; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; LIVER DISEASES; LUNG DISEASES; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33644905318     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02523.x     Document Type: Review

References (103)

1. Poole PJ Black PN Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease (Cochrane Review). In: The Cochrane Library, Issue 3. Chichester John Wiley & Sons Ltd 2004
2. Zafarullah M Li WQ Sylvester J Ahmad M Molecular mechanisms of N-acetylcysteine actions Cell Mol Life Sci 2003 60 6 20
3. De Rosa SC Zaretsky MD Dubs JG Roederer M Anderson M Green A Mitra D Watanabe N Nakamura H Tjioe I Deresinski SC Moore WA Ela SW Parks D Herzenberg LA Herzenberg LA N-acetylcysteine replenishes glutathione in HIV infection Eur J Clin Invest 2000 30 915 29
4. Galli F Ghibelli L Buoncristiani U Bordoni V D'Intini V Benedetti S Canestrari F Ronco C Floridi A Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E Nephrol Dial Transplant 2003 18 1592 600
5. Himmelfarb J Hakim RM Oxidative stress in uremia Curr Opin Nephrol Hypertens 2003 12 593 8
6. Molnar Z Szakmany T Koszegi T Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial Intensive Care Med 2003 29 749 55
7. Taniyama Y Griendling KK Reactive oxygen species in the vasculature: molecular and cellular mechanisms Hypertension 2003 42 1075 81
8. Raj DS Lim G Levi M Qualls C Jain SK Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy Am J Kidney Dis 2004 43 154 60
9. Marczin N Bundy RE Hoare GS Yacoub M Redox regulation following cardiac ischemia and reperfusion Coron Artery Dis 2003 14 123 33
10. Selzner N Rudiger H Graf R Clavien PA Protective strategies against ischemic injury of the liver Gastroenterology 2003 125 917 36
11. Sevillano S de la Mano AM de Dios I Ramudo L Manso MA Major pathological mechanisms of acute pancreatitis are prevented by N-acetylcysteine Digestion 2003 68 34 40
12. Santangelo F Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach Curr Med Chem 2003 10 2599 610
13. Dröge W Breitkreutz R Glutathione and immune function Proc Nutr Soc 2000 59 595 600
14. Bernhard D Pfister G Huck CW Kind M Salvenmoser W Bonn GK Wick G Disruption of vascular endothelial homeostasis by tobacco smoke - impact on atherosclerosis FASEB J 2003 17 2302 4
15. Cotgreave IA N-acetylcysteine: pharmacological considerations and experimental and clinical applications Adv Pharmacol 1997 38 205 27
16. Cavallini L Alexandre A Oral N-acetyl-cysteome increases the production of anti HIV chemokines in peripheral blood mononuclear cells Life Sci 2000 67 147 54
17. Omara FO Fournier M Vincent R Blakley BR Suppression of rat and mouse lymphocyte function by urban air particulates (Ottawa dust) is reversed by N-acetylcysteine J Toxicol Environ Health A 2000 59 67 85
18. Guayerbas N Puerto M Ferrandez MD De La Fuente M A diet supplemented with thiolic anti-oxidants improves leucocyte function in two strains of prematurely ageing mice Clin Exp Pharmacol Physiol 2002 29 1009 14
19. Rocha-Vieira E Ferreira E Vianna P De Faria DR Gaze ST Dutra WO Gollob KJ Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-1-cysteine Immunology 2003 108 401 8
20. Ungheri D Pisani C Sanson G Bertani A Schioppacassi G Delgado R Sironi M Ghezzi P Protective effect of N-acetylcysteine in a model of influenza infection in mice Int J Immunopathol Pharmacol 2000 13 123 8
21. Hirano S Furuyama A Koike E Kobayashi T Oxidative-stress potency of organic extracts of diesel exhaust and urban fine particles in rat heart microvessel endothelial cells Toxicology 2003 187 161 70
22. Galis ZS Asanuma K Godin D Meng X N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation 1998 97 2445 53
23. Ghigliotti G Mereto E Eisenberg PR Martelli A Orsi P Sini D Spallarossa P Olivotti L Brunelli C N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of New Zealand white rabbits Thromb Haemost 2001 85 724 9
24. Girouard H Chulak C Wu L Lejossec M de Champlain J N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats Am J Hypertens 2003 16 577 84
25. Bourraindeloup M Adamy C Candiani G Cailleret M Bourin MC Badoual T Su JB Adubeiro S Roudot-Thoraval F Dubois-Rande JL Hittinger L Pecker F N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats Circulation 2004 110 2003 9
26. Calvillo L Masson S Salio M Pollicino L De Angelis N Fiordaliso F Bai A Ghezzi P Santangelo F Latini R In vivo cardioprotection by N-acetylcysteine and isosorbide 5-mononitrate in a rat model of ischemia-reperfusion Cardiovasc Drugs Ther 2003 17 199 208
27. Fischer UM Tossios P Huebner A Geissler HJ Bloch W Mehlhorn U Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery J Thorac Cardiovasc Surg 2004 128 103 8
28. Das SK Mukherjee S Smith MG Chatterjee D Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue J Biochem Mol Toxicol 2003 17 177 84
29. Cakir O Oruc A Kaya S Eren N Yildiz F Erdinc L N-acetylcysteine reduces lung reperfusion injury after deep hypothermia and total circulatory arrest J Card Surg 2004 19 221 5
30. Hagiwara SI Ishii Y Kitamura S Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice Am J Respir Crit Care Med 2000 162 225 31
31. Chen GJ Xu J Lahousse SA Caggiano NL de la Monte SM Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection J Alzheimers Dis 2003 5 209 28
32. Hart AM Terenghi G Kellerth JO Wiberg M Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of N-acetyl-cysteine after nerve injury Neuroscience 2004 125 91 101
33. Farr SA Poon HF Dogrukol-Ak D Drake J Banks WA Eyerman E Butterfield DA Morley JE The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice J Neurochem 2003 84 1173 83
34. Ohinata Y Miller JM Schacht J Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea Brain Res 2003 966 265 73
35. Glantzounis GK Yang W Koti RS Mikhailidis DP Seifalian AM Davidson BR Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury Br J Surg 2004 91 1330 9
36. Huynh HQ Couper RT Tran CD Moore L Kelso R Butler RN N-acetylcysteine, a novel treatment for Helicobacter pylori infection Dig Dis Sci 2004 49 1853 61
37. Odetti P Pesce C Traverso N Menini S Maineri EP Cosso L Valentini S Patriarca S Cottalasso D Marinari UM Pronzato MA Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 2003 52 499 505
38. Haber CA Lam TK Yu Z Gupta N Goh T Bogdanovic E Giacca A Fantus IG N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress Am J Physiol Endocrinol Metab 2003 285 E744 53
39. Lean JM Davies JT Fuller K Jagger CJ Kirstein B Partington GA Urry ZL Chambers TJ A crucial role for thiol antioxidants in estrogen-deficiency bone loss J Clin Invest 2003 112 915 23
40. Bisseling TM Maria Roes E Raijmakers MT Steegers EA Peters WH Smits P N-acetylcysteine restores nitric oxide-mediated effects in the fetoplacental circulation of preeclamptic patients Am J Obstet Gynecol 2004 191 328 33
41. Neal R Matthews RH Lutz P Ercal N Antioxidant role of N-acetyl cysteine isomers following high dose irradiation Free Radic Biol Med 2003 34 689 95
42. Kang S Chung JH Lee JH Fisher GJ Wan YS Duell EA Voorhees JJ Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo J Invest Dermatol 2003 120 835 41
43. Ventura P Panini R Abbati G Marchetti G Salvioli G Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy Pharmacology 2003 68 105 14
44. Fishbane S Durham JH Marzo K Rudnick M N-acetylcysteine in the prevention of radiocontrast-induced nephropathy J Am Soc Nephrol 2004 15 251 60
45. Witko-Sarsat V Gausson V Nguyen AT Touam M Drueke T Santangelo F Descamps-Latscha B AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients Kidney Int 2003 64 82 91
46. Efrati S Averbukh M Berman S Feldman L Dishy V Kachko L Weissgarten J Golik A Averbukh Z N-Acetylcysteine ameliorates lithium-induced renal failure in rats Nephrol Dial Transplant 2005 20 65 70
47. Feldman L Efrati S Dishy V Katchko L Berman S Averbukh M Aladjem M Averbukh Z Weissgarten J N-acetylcysteine ameliorates amphotericin-induced nephropathy in rats Nephron Physiol 2005 99 23 7
48. Van Schooten FJ Besarati Nia A De Flora S D'Agostini F Izzotti A Camoirano A Balm AJ Dallinga JW Bast A Haenen GR Van't Veer L Baas P Sakai H Van Zandwijk N Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers Cancer Epidemiol Biomarkers Prev 2002 11 167 75
49. Mantovani G Maccio A Madeddu C Mura L Gramignano G Lusso MR Massa E Mocci M Serpe R Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress J Mol Med 2003 81 664 73
50. Locatelli F Canaud B Eckardt KU Stenvinkel P Wanner C Zoccali C Oxidative stress in end-stage renal disease: an emerging threat to patient outcome Nephrol Dial Transplant 2003 18 1272 80
51. Allegra L Dal Sasso M Bovio C Massoni C Fonti E Braga PC Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations Arzneimittelforschung 2002 52 669 76
52. De Flora S Grassi C Carati L Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment Eur Respir J 1997 10 1535 41
53. Pasvol G Management of severe malaria: interventions and controversies Infect Dis Clin North Am 2005 19 211 40
54. De Benedetto F Aceto A Dragani B Spacone A Formisano S Pela R Donner CF Sanguinetti CM Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD Pulm Pharmacol Ther 2005 18 41 7
55. Black PN Morgan-Day A McMillan TE Poole PJ Young RP Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344] BMC Pulm Med 2004 4 13
56. Grandjean EM Berthet PH Ruffman R Leuenberger PH Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled trials Clin Ther 2000 22 209 20
57. Stey C Steurer J Bachmann S Medici TC Tramer MR The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review Eur Respir J 2000 16 253 62
58. Gerrits CM Herings RM Leufkens HG Lammers JW N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease Eur Respir J 2003 21 795 8
59. Decramer M Rutten-van Molken M Dekhuijzen PN Troosters T van Herwaarden C Pellegrino R van Schayck CP Olivieri D Del Donno M De Backer W Lankhorst I Ardia A Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial Lancet 2005 365 1552 60
60. Duijvestijn YC Brand PL Systematic review of N-acetylcysteine in cystic fibrosis Acta Paediatr 1999 88 38 41
61. Behr J Degenkolb B Krombach F Vogelmeier C Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine Eur Respir J 2002 19 906 11
62. Adhikari N Burns K Meade M Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome The Cochrane Database of Systematic Reviews, Issue 4. Art. no. CD004477.pub2. DOI: 10.1002/14651858. CD004477.pub2. 2004
63. Ahola T Lapatto R Raivio KO Selander B Stigson L Jonsson B Jonsbo F Esberg G Stovring S Kjartansson S Stiris T Lossius K Virkola K Fellman V N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial J Pediatr 2003 143 713 9
64. Sandberg K Fellman V Stigson L Thiringer K Hjalmarson O N-Acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants Biol Neonate 2004 86 275 9
65. Sklar GE Subramaniam M Acetylcysteine treatment for non-acetaminophen- induced acute liver failure Ann Pharmacother 2004 38 498 500
66. Taut FJ Breitkreutz R Zapletal CM Thies JC Babylon A Martin E Droge W Influence of N-acetylcysteine on hepatic amino acid metabolism in patients undergoing orthotopic liver transplantation Transpl Int 2001 14 329 33
67. Grant PR Black A Garcia N Prieto J Garson JA Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study J Med Virol 2000 61 439 42
68. Neri S Ierna D Antoci S Campanile E D'Amico RA Noto R Association of alpha-interferon and acetyl cysteine in patients with chronic C hepatitis Panminerva Med 2000 42 187 92
69. Tepel M Zidek W N-Acetylcysteine in nephrology; contrast nephropathy and beyond Curr Opin Nephrol Hypertens 2004 13 649 54
70. Webb JG Pate GE Humphries KH Buller CE Shalansky S Al Shamari A Sutander A Williams T Fox RS Levin A A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect Am Heart J 2004 148 422 9
71. Hoffmann U Fischereder M Kruger B Drobnik W Kramer BK The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable J Am Soc Nephrol 2004 15 407 10
72. Pannu N Manns B Lee H Tonelli M Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 2004 65 1366 74
73. Bagshaw SM Ghali WA Bagshaw SM Ghali WA Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis BMC Med 2004 2 38
74. Misra D Leibowitz K Gowda RM Shapiro M Khan IA Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis Clin Cardiol 2004 27 607 10
75. Nallamothu BK Shojania KG Saint S Hofer TP Humes HD Moscucci M Bates ER Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis Am J Med 2004 117 938 47
76. Duong MH MacKenzie TA Malenka DJ N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis Catheter Cardiovasc Interv 2005 64 471 9
77. Miner SE Dzavik V Nguyen-Ho P Richardson R Mitchell J Atchison D Seidelin P Daly P Ross J McLaughlin PR Ing D Lewycky P Barolet A Schwartz L N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up Am Heart J 2004 148 690 5
78. Ochoa A Pellizzon G Addala S Grines C Isayenko Y Boura J Rempinski D O'Neill W Kahn J Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention J Interv Cardiol 2004 17 159 65
79. Holt S Goodier D Marley R Patch D Burroughs A Fernando B Harry D Moore K Improvement in renal function in hepatorenal syndrome with N-acetylcysteine Lancet 1999 353 294 5
80. van Zandwijk N Dalesio O Pastorino U de Vries N van Tinteren H EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups J Natl Cancer Inst 2000 92 977 86
81. Sjöö F Aschan J Barkholt L Hassan Z Ringden O Hassan M N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation Bone Marrow Transplant 2003 32 349 54
82. Sochman J N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know? J Am Coll Cardiol 2002 39 1422 8
83. Gavish D Breslow JL Lipoprotein(a) reduction by N-acetylcysteine Lancet 1991 337 203 4
84. Eren N Cakir O Oruc A Kaya Z Erdinc L Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass Perfusion 2003 18 345 50
85. Angdin M Settergren G Starkopf J Zilmer M Zilmer K Vaage J Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass J Cardiothorac Vasc Anesth 2003 17 314 20
86. Sucu N Cinel I Unlu A Aytacoglu B Tamer L Kocak Z Karaca K Gul A Dikmengil M Atik U Oral U N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass Surg Today 2004 34 237 42
87. Heller AR Groth G Heller SC Breitkreutz R Nebe T Quintel M Koch T N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients Crit Care Med 2001 29 272 6
88. Szakmany T Marton S Molnar Z Lack of effect of prophylactic N-acetylcysteine on postoperative organ dysfunction following major abdominal tumour surgery: a randomized, placebo-controlled, double-blinded clinical trial Anaesth Intensive Care 2003 31 267 71
89. Emet S Memis D Pamukcu Z The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis Crit Care 2004 8 R172 9
90. Spapen HD Diltoer MW Nguyen DN Hendrickx I Huyghens LP Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study Chest 2005 127 1413 9
91. Montanini S Sinardi D Pratico C Sinardi AU Trimarchi G Use of acetylcysteine as the life-saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients Arzneimittelforschung 1999 49 1044 7
92. Louwerse ES Weverling GJ Bossuyt PM Meyjes FE de Jong JM Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis Arch Neurol 1995 52 559 64
93. Hauer K Hildebrandt W Sehl Y Edler L Oster P Droge W Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment J Mol Med 2003 81 118 25
94. Perez RS Zuurmond WW Bezemer PD Kuik DJ van Loenen AC de Lange JJ Zuidhof AJ The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study Pain 2003 102 297 307
95. Ovesen T Felding JU Tommerup B Schousboe LP Petersen CG Effect of N-acetylcysteine on the incidence of recurrence of otitis media with effusion and re-insertion of ventilation tubes Acta Otolaryngol Suppl 2000 543 79 81
96. Fulghesu AM Ciampelli M Muzj G Belosi C Selvaggi L Ayala GF Lanzone A N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome Fertil Steril 2002 77 1128 35
97. Pace BS Shartava A Pack-Mabien A Mulekar M Ardia A Goodman SR Effects of N-acetylcysteine on dense cell formation in sickle cell disease Am J Hematol 2003 73 26 32
98. Redondo P Bauza A Topical N-acetylcysteine for lamellar ichthyosis Lancet 1999 354 1880
99. Walters MT Rubin CE Keightley SJ Ward CD Cawley MI A double-blind, cross-over study of oral N-acetylcysteine in Sjögren's syndrome Scand J Rheumatol Suppl 1986 61 253 8
100. Sambo P Amico D Giacomelli R Matucci-Cerinic M Salsano F Valentini G Gabrielli A Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study J Rheumatol 2001 28 2257 62
101. Yalcin E Altin F Cinhuseyinoglue F Arslan MO N-acetylcysteine in chronic blepharitis Cornea 2002 21 164 8
102. Claes P Wintzen M Allard S Simons P De Coninck A Lacor P Nevirapine-induced toxic epidermal necrolysis and toxic hepatitis treated successfully with a combination of intravenous immunoglobulins and N-acetylcysteine Eur J Intern Med 2004 15 255 8
103. Phillips DC Woollard KJ Griffiths HR The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species Br J Pharmacol 2003 138 501 11